High-grade dysplasia in Barrett's oesophagus

British Journal of Surgery

Volumn 84, Issue 6, 1997, Pages 760-766

  Wright, T A ^a  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BARRETT ESOPHAGUS; DYSPLASIA; ELECTROCOAGULATION; ESOPHAGUS CANCER; HUMAN; LASER SURGERY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; REVIEW;

BARRETT ESOPHAGUS; DIAGNOSIS, DIFFERENTIAL; ENDOSCOPY, DIGESTIVE SYSTEM; ESOPHAGEAL NEOPLASMS; HUMANS; PHOTOCHEMOTHERAPY; PRECANCEROUS CONDITIONS;

EID: 0030960444     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840606     Document Type: Review

References (79)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991; 265: 1287-9.
2. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104: 510-13.
3. Haggitt RC. Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol 1992; 23: 475-6 (Editorial).
4. Menke-Pluymers MBE, Schoute NW, Mulder AH, Hop WCJ, Van Blankenstein M, Tilanus HW. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut 1992; 33: 1454-8.
5. Li H, Walsh TN, Hennessy TPJ. Carcinoma arising in Barrett's esophagus. Surg Gynecol Obstet 1992; 175: 167-72.
6. Thomas RJS, Mullerworth MW, Bhathal PS, Gregory PJ, St John DJB. The results of surgery as first treatment for oesophageal cancer - a hospital based prospective study. Diseases of the Esophagus 1994; 7: 179-83.
7. Akiyama H, Tsurumaru M, Udagawa H, Kajiyama Y. Systematic lymph node dissection for esophageal cancer - effective or not? Diseases of the Esophagus 1994; 7: 2-13.
8. Rusch VW, Levine DS, Haggitt R, Reid BJ. The management of high grade dysplasia and early cancer in Barrett's esophagus. A multidisciplinary problem. Cancer 1994; 74: 1225-9.
9. Hamilton SR, Smith RRL, Cameron JL. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol 1988; 19: 942-8.
10. Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology 1995; 109: 1541-6.
11. Haggitt RC, Tryzelaar J, Ellis FH, Coleher H. Adenocarcinoma complicating columnar epithelium-lined (Barrett's) esophagus. Am J Clin Pathol 1978; 70: 1-5.
12. Dent J, Bremner C-G, Collen MJ, Haggitt RC, Spechler SJ. Barrett's oesophagus. J Gastroenterol Hepatol 1991; 6: 1-22.
13. Wright TA, Gray MR, Morris AI et al. Cost effectiveness of detecting Barrett's cancer. Gut 1996; 39: 574-9.
14. Morson BC, Sobin LH, Grundmann E, Johansen A, Nagayo T, Serck-Hanssen A. Precancerous conditions and epithelial dysplasia in the stomach. J Clin Pathol 1980; 33: 711-21.
15. Riddell RH, Goldman H, Ransohoff DF et al. Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 1983; 14: 931-68.
16. Thompson JJ, Zinsser KR, Enterline HT. Barrett's metaplasia and adenocarcinoma of the esophagus and gastroesophageal junction. Hum Pathol 1983; 14: 42-61.
17. Reid BJ, Haggitt RC, Rubin CE et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. Hum Pathol 1988; 19: 166-78.
18. Reid BJ, Weinstein WM, Lewin KJ, Haggitt RC, Van Derventer G, Den Besten L, Rubin CE. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions. Gastroenterology 1988; 94: 81-90.
19. Robey SS, Hamilton SR, Gupta PK, Erozan YS. Diagnostic value of cytopathology in Barrett esophagus and associated carcinoma. Am J Clin Pathol 1988; 89: 493-8.
20. Belladonna JA, Hajdu SI, Bains MS, Winawer SJ. Adenocarcinoma in situ of Barrett's esophagus diagnosed by endoscopic cytology. N Engl J Med 1974; 291: 895-6.
21. Wang HH, Doria MI Jr, Purohit-Buch S, Schnell T, Sontag S, Chejfec G. Barrett's esophagus. The cytology of dysplasia in comparison to benign and malignant lesions. Acta Cytol 1992; 36: 60-4.
22. Geisinger KR, Teot LA, Richter JE. A comparative cytopathologic and histologic study of atypia, dysplasia, and adenocarcinoma in Barrett's esophagus. Cancer 1992; 69: 8-16.
23. Reid BJ, Haggitt RC, Rubin CE, Rabinovitch PS. Barrett's esophagus. Correlation between flow cytometry and histology in detection of patients at risk of adenocarcinoma. Gastroenterology 1987; 93: 1-11.
24. James PD, Atkinson M. Value of DNA image cytometry in the prediction of malignant change in Barrett's oesophagus. Gut 1989; 30: 899-905.
25. Reid BJ, Blount PL, Rubin CE, Levine DS, Haggitt RC, Rabinovitch PS. Flow-cytometric and histological progression to malignancy in Barrett's esophagus: prospective endoscopic surveillance of a cohort. Gastroenterology 1992; 102: 1212-19.
26. Fennerty MB, Sampliner RE, Way D, Riddell R, Steinbronn K, Garewal HS. Discordance between flow cytometric abnormalities and dysplasia in Barrett's esophagus. Gastroenterology 1989; 97: 815-20.
27. Menke-Pluymers MBE, Mulder AH, Hop WCJ, van Blankenstein M, Tilanus HW. Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut 1994; 35: 1348-51.
28. DeMeester TR, Attwood SEA, Smyrk TC, Therkildsen DH, Hinder RA. Surgical therapy in Barrett's esophagus. Ann Surg 1990; 212: 528-42.
29. Streitz JM Jr, Andrews CW Jr, Ellis FH Jr. Endoscopic surveillance of Barrett's esophagus. Does it help? J Thorac Cardiovasc Surg 1993; 105: 383-8.
30. Skinner DB, Walther BC, Riddell RH, Schmidt H, Iascone C, DeMeester TR. Barrett's oesophagus. Comparison of benign and malignant cases. Ann Surg 1983; 198: 554-65.
31. Williamson WA, Ellis FH Jr, Gibb SP et al. Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med 1991; 151: 2212-16.
32. McArdle JE, Lewin KJ, Randall G, Weinstein W. Distribution of dysplasias and early invasive carcinoma in Barrett's esophagus. Hum Pathol 1992; 23: 479-82.
33. Hamilton SR, Smith RRL. The relationship between columnar epithelial dysplasia and invasive adenocarcinoma arising in Barrett's esophagus. Am J Clin Pathol 1987; 87: 301-12.
34. Rosenberg JC, Budev H, Edwards RC, Singal S, Steiger Z, Sundareson AS. Analysis of adenocarcinoma in Barrett's esophagus utilizing a staging system. Cancer 1985; 55: 1353-60.
35. Pera M, Trastek VF, Carpenter HA, Allen MS, Deschamps C, Pairolero PC. Barrett's esophagus with high-grade dysplasia: an indication for esophagectomy? Ann Thorac Surg 1992; 54: 199-204.
36. Hammeteman W, Tytgat GNJ, Houthoff HJ, van den Tweel JG. Barrett's esophagus: development of dysplasia and adenocarcinoma. Gastroenterology 1989; 96: 1249-56.
37. Burke AP, Sobin LH, Shekitka KM, Helwig EB. Dysplasia of the stomach and Barrett esophagus: a follow-up study. Mod Pathol 1991; 4: 336-41.
38. Miros M, Kerlin P, Walker N. Only patients with dysplasia progress to adenocarcinoma in Barrett's oesophagus. Gut 1991; 32: 1441-6.
39. Atkinson M, Iftikhar SY, James PD, Robertson CS, Steele RJC. The early diagnosis of oesophageal adenocarcinoma by endoscopie screening. Eur J Cancer Prev 1992; 1: 327-30.
40. De Baecque C, Potet F, Molas G, Flejou JF, Barbier P, Martignon C. Superficial adenocarcinoma of the oesophagus arising in Barrett's mucosa with dysplasia: a clinicopathological study of 12 patients. Histopathology 1990; 16: 213-20.
41. Schnell T, Sontag S, Chejfec G, Chintam R, O'Connell S, Kurucar C. High grade dysplasia in Barrett's esophagus: a report of experience in 43 patients. Gastroenterology 1989; 96(Suppl): A452 (Abstract).
42. Levine DS, Haggitt RC, Blount PL, Rabinovitch PS, Rusch VW, Reid BJ. An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology 1993; 105: 40-50.
43. Levine DS, Haggitt RC, Rabinovitch PS, Reid BJ. Complete regression of high-grade dysplasia, DNA content abnormalities and Barrett's esophagus. Gastroenterology 1995; 108(Suppl): A496 (Abstract).
44. Lee RG. Dysplasia in Barrett's esophagus. A clinicopathological study of six patients. Am J Surg Pathol 1985; 9: 845-52.
45. Rice TW, Falk GW, Achkar E, Petras RE. Surgical management of high-grade dysplasia in Barrett's esophagus. Am J Gastroenterol 1993; 88: 1832-6.
46. Altorki NK, Sunagawa M, Little AG, Skinner DB. High-grade dysplasia in the columnar-lined esophagus. Am J Surg 1991; 161: 97-9.
47. Wright TA, Myskow MW, Nash J, Gray M, Kingsnorth AN. High grade dysplasia in Barrett's oesophagus. How should it be managed? Gut 1994; 35(Suppl 2): S22 (Abstract).
48. Edwards MJ, Gable DR, Lentsch AB, Richardson JD. The rationale for esophagectomy as the optimum therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg 1996; 223: 585-91.
49. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996; 224: 66-71.
50. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986; 315: 362-71.
51. Lerut T, Coosemans W, Van Raemdonck D et al. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis. J Thorac Cardiovasc Surg 1994; 107: 1059-65.
52. Cameron AJ, Carpenter HA. Barrett's oesophagus, high grade dysplasia and early adenocarcinoma. Comparison of endoscopic biopsy and surgical pathology findings. Gut 1996; 38(Suppl): A23 (Abstract).
53. Ziegler K, Sanft C, Zeitz M et al. Evaluation of endosonography in TN staging of oesophageal cancer. Gut 1991; 32: 16-20.
54. Srivastava AK, Vanagunas A, Kamel P, Cooper R. Endoscopic ultrasound in the evaluation of Barrett's esophagus: a preliminary report. Am J Gastroenterol 1994; 89: 2192-5.
55. Yoshikane H, Tsukamoto Y, Niwa Y et al. Superficial esophageal carcinoma: evaluation by endoscopic ultrasonography. Am J Gastroenterol 1994; 89: 702-7.
56. Falk GW, Catalano MF, Sivak MV Jr, Rice TW, Van Dam J. Endosonography in the evaluation of patients with Barrett's esophagus and high-grade dysplasia. Gastrointest Endosc 1994; 40: 207-12.
57. Gore S, Healey CJ, Sutton R et al. Regression of columnar lined (Barrett's) oesophagus with continuous omeprazole therapy. Aliment Phamacol Ther 1993; 7: 623-8.
58. Sampliner RE, Fass R. Partial regression of Barrett's esophagus - an inadequate end point. Am J Gastroenterol 1993; 88: 2092-4.
59. Van der Veen AH, Dees J, Blankensteijn JD, Van Blankenstein M. Adenocarcinoma in Barrett's oesophagus: an overrated risk. Gut 1989; 30: 14-18.
60. Hamilton SR, Hutcheon DF, Ravich WJ, Cameron JL, Paulson M. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux. Gastroenterology 1984; 86: 356-60.
61. Attwood SEA, Barlow AP, Norris TL, Watson A. Barrett's oesophagus: effect of antireflux surgery on symptom control and development of complications. Br J Surg 1992; 79: 1050-3.
62. Cuschieri A, Shimi S, Banting S. Endoscopic oesophagectomy through a right thoracoscopic approach. J R Coll Surg Edinb 1992; 37: 7-11.
63. Robertson GSM, Lloyd DM, Wicks ACB, Veitch PS. No obvious advantages for thoracoscopic two-stage oesophagectomy. Br J Surg 1996; 83: 675-8.
64. McAnena OJ, Rogers J, Williams NS. Right thoracoscopically assisted oesophagectomy for cancer. Br J Surg 1994; 81: 236-8.
65. Gillen P, Keeling P, Byrne PJ, West AB, Hennessy TPJ. Experimental columnar metaplasia in the canine oesophagus. Br J Surg 1988; 75: 113-15.
66. Brandt LJ, Kauvar DR. Laser-induced transient regression of Barrett's epithelium. Gastrointest Endosc 1992; 38: 619-22.
67. Berenson MM, Johnson TD, Markowitz NR, Buchi KN, Samowitz WS. Restoration of squamous mucosa after ablation of Barrett's epithelium. Gastroenterology 1993; 104: 1686-91.
68. Sampliner RE, Fennerty MB, Garewal HS. Controlled trial of reversal of Barrett's esophagus with acid suppression and multi-polar electrocoagulation (MEPC). Gastroenterology 1995; 108(Suppl): A208 (Abstract).
69. Fremond L, Bouche O, Diebold MD, Demange L, Zeitoun P, Thiefin G. Partial regression of Barrett esophagus with high grade dysplasia and adenocarcinoma after photocoagulation and endocurietherapy under antisecretory treatment. Gastroenterol Clin Biol 1995; 19: 112-16.
70. Salo JA, Nemlander A, Färkkilä M, Kiviluoto T, Kivilaakso E. Treatment of Barrett's metaplasia by antireflux surgery and endoscopic laser ablation: clinical experience in ten patients. Gastroenterology 1995; 108(Suppl): A1243 (Abstract).
71. Endo M, Takeshita K, Inoue H. Endoscopic mucosal resection of esophageal cancer. Gan To Kagaku Ryoho 1995; 22: 192-5.
72. Regula J, MacRobert AJ, Gorchein A et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphorin IX - a pilot study. Gut 1995; 36: 67-75.
73. Overholt B, Panjehpour M, Tefftellar E, Rose M. Photodynamic therapy for treatment of early adenocarcinoma in Barrett's esophagus. Gastrointest Endosc 1993; 39: 73-6.
74. Gutta K, Wang KK, Densmore J, Geller A. A non-invasive determination of drug level in photodynamic therapy of Barrett's esophagus. Gastroenterology 1995; 108(Suppl), A477 (Abstract).
75. Tajiri H, Daikuzono N, Joffe SN, Oguro Y. Photoradiation therapy in early gastrointestinal cancer. Gastrointest Endosc 1987; 33: 88-90.
76. Fujimaki M, Nakayama K. Endoscopic laser treatment of superficial esophageal cancer. Semin Surg Oncol 1986; 2: 248-56.
77. Gossner L, Hahn EG, Ell C. Photodynamic therapy using 5-aminolaevulinic acid in esophageal dysplasia and carcinoma in situ. Gastroenterology 1995; 108(Suppl); A475 (Abstract).
78. Foultier MT, Vonarx-Coinsman V, de Brito LX, Morlet L, Robillard N, Patrice T. DNA or cell kinetics flow cytometry analysis of 33 small gastrointestinal cancers treated by photodynamic therapy. Cancer 1994; 73: 1595-607.
79. Barr H, Dix T, Roberts D, Shephard N. Eradication of high grade dysplasia in columnar lined (Barrett's) oesophagus by photodynamic therapy with oral 5-aminolaevulinic acid and 630 nm light. Gut 1994; 35: S7.